![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.547, 2008-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Outpatient Therapy for Febrile Neutropenia: Clinical and Economic Implications
By de Lalla F.
PharmacoEconomics, Vol. 21, Iss. 6, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Outpatient Management of Febrile Neutropenia in Children with Cancer
Pediatric Drugs, Vol. 5, Iss. 7, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Febrile neutropenia costly in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Hold the antibacterials in febrile neutropenia
Reactions Weekly, Vol. 1, Iss. 1083, 2006-01 ,pp. :